| GENESIS GROUP INC. Patent applications |
| Patent application number | Title | Published |
|---|
| 20120132124 | SPAR Based Maritime Access Vehicle - The invention relates to a spar based vessel for accessing offshore installations and vessels, including wind farm turbines, in which the centre of gravity of the vessel is positioned below the centre of buoyancy, which is positioned below the operational waterline, the operational waterline occurs at low cross-sectional area vertical struts, and the vertical struts support a topside structure for passengers. Active ballast control system and location of the propulsive elements permits the vessel to travel in spar orientation by positioning the vector of propulsion to lie in the same horizontal plane as the transverse centre of drag of the vessel. A docking system permits safe connection of the vessel to offshore installations, including wind turbines of generic design. | 05-31-2012 |
| 20110038536 | REAL-TIME IMAGE AND VIDEO MATTING - A system and method implemented as a software tool for generating alpha matte sequences in real-time for the purposes of background or foreground substitution in digital images and video. The system and method is based on a set of modified Poisson equations that are derived for handling multichannel color vectors. Greater robustness is achieved by computing an initial alpha matte in color space. Real-time processing speed is achieved through optimizing the algorithm for parallel processing on the GPUs. For online video matting, a modified background cut algorithm is implemented to separate foreground and background, which guides the automatic trimap generation. Quantitative evaluation on still images shows that the alpha mattes extracted using the present invention has improved accuracy over existing state-of-the-art offline image matting techniques. | 02-17-2011 |
| 20090291856 | DIAGNOSTIC TEST FOR CARDIOMYOPATHY - Methods and compositions relating to diagnosing and treating cardiomyopathy and particularly relating to methods and compositions for diagnosing and treating arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) are described. Provided are methods for screening for, diagnosing or detecting a risk of developing arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) comprising detecting the presence of a transmembrane protein 43 (TMEM43) disease associated variant in a sample of a subject, wherein the presence of a TMEM43 disease variant is indicative that the subject has ARVD/C or an increased risk of developing ARVD/C compared to an individual having wild type TMEM43. | 11-26-2009 |
